/ Active, not recruiting早期临床1期 A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors
The purpose of this clinical trial is to evaluate the safety and tolerability of SXRN Plasmid DNA Technique in patients with advanced solid tumors.
100 项与 江苏核泰生物有限公司 相关的临床结果
0 项与 江苏核泰生物有限公司 相关的专利(医药)
100 项与 江苏核泰生物有限公司 相关的药物交易
100 项与 江苏核泰生物有限公司 相关的转化医学